The Prospects of Vitamin C in Cancer Therapy
Author:
Open Access
- 1 January 2009
- journal article
- Published by The Korean Association of Immunobiologists in Immune Network
- Vol. 9 (5) , 147-152
Abstract
Lee WJ. Immune Netw. 2009 Oct;9(5):147-152. http://dx.doi.org/10.4110/in.2009.9.5.147Keywords
This publication has 63 references indexed in Scilit:
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProceedings of the National Academy of Sciences, 2008
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoProceedings of the National Academy of Sciences, 2007
- Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years LaterIntegrative Cancer Therapies, 2005
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- New Concepts in the Biology and Biochemistry of Ascorbic AcidNew England Journal of Medicine, 1986
- The Biochemical Functions of Ascorbic AcidAnnual Review of Nutrition, 1986
- High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior ChemotherapyNew England Journal of Medicine, 1985
- Inhibiting Effect of Dehydroascorbic Acid on Cell Division in Ascites Tumors in MicePathobiology, 1982
- Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced CancerNew England Journal of Medicine, 1979
- The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancerChemico-Biological Interactions, 1974